Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus

Lupus

Volumn 8, Issue 3, 1999, Pages 227-233

  Harigai, M ^a   Hara, M ^a   Fukasawa, C ^a   Nakazawa, S ^a   Kawaguchi, Y ^a   Kamatani, N ^a   Kashiwazaki, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti DNA antibody; B lymphocyte; CD40; CD40 ligand; Systemic lupus erythematosus

Indexed keywords

CD40 ANTIGEN; DNA; DNA ANTIBODY; GLYCOPROTEIN GP 39; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032891884     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678847678     Document Type: Article

References (44)

1. Burlingame R, Boey M, Starkebaum G et al. The central role of chromatin in autoimmune responses to histones and DNA in SLE. J Clin Invest 1994; 94: 184-192.
2. Radic M, Weigert M. Genetic and structural evidence for antigen selecton of anti-DNA antibodies. Annu Rev Immunol 1994; 12: 487-520.
3. Pharm B et al., T lymphocyte activation in systemic lupus erythematosus analyzed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots. Clin Exp Immunol 1989; 77: 168-174.
4. Crow M et al., Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J Clin Invest 1994; 94: 345-352.
5. Suenaga R, Abdou N. Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol 1993; 94: 418-422.
6. Gavalchin J, Datta S. The NZB×SWR model of lupus nephritis II. Autoantibodies deposted in renal lesions show a restricted idiotypic diversity. J Immunol 1987; 138: 138-148.
7. Do Valerio R, Bernstein K, Varghese E, Lefkowith J. Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism. J Immunol 1995; 155: 2258-2268.
8. Hara M et al. Differential abnormalilty in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus. Rheumatol Int 1987; 7: 83-87.
9. Kitani et al. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with SLE. Clin exp Immunol 1989; 77: 31-36.
10. Kitani A et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin exp Immunol 1992; 88: 75-83.
11. Clark L, Foy T, Noelle R. CD40 and its ligand. Adv Immunol 1996; 63: 43-78.
12. Roy M et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993; 151: 2497-2510.
13. Valle A et al. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J Immunol 1989; 19: 1463-1467.
14. Saeland S, Duvert V, Moreau I, Banchereau J. Human B cell precursors proliferate and express CD23 after CD40 ligation. J Exp Med 1993; 178: 113-120.
15. Klaus S, Berberich I, Shu G et al. CD40 and its ligand in the regulation of humoral immunity. Semin Immunol 1994; 6: 279-286.
16. Barrett T, Shu G, Clark E . CD40 signalling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 1991; 146: 1722-1729.
17. Ranheim E, Kipps T. Activated T cells induce expression of B7/BB-1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993; 177: 925-935.
18. Ranheim E, Kipps T. Tumor necrosis factor-a facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by 1L-4, IL-10, and CD40L. Cell Immunol 1995; 161: 226-235.
19. Roy M et al. Studies on the interdependence of gp39 and B7 expressio? and function during antigen specific immune responses. Eur J Immuno 1994; 25: 596-603.
20. Allen R et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990-993.
21. Aruffo A et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291-300.
22. Fuleihan R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993; 90: 2170-2173.
23. Ramesh N et al. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 1993; 5: 769-773.
24. DiSanto J et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541-543.
25. Conley M et al. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest 1994; 4: 1404-1409.
26. Tan E et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
27. Bombardier C et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
28. Fanslow W et al. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 1994; 6: 267-278.
29. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-3692.
30. Tsubata T, Wu J, Honjo T. B cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993; 364: 645-648.
31. Holder MJ et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 1993; 23: 2368-2371.
32. Armitage R, Macduff B, Spriggs M et al. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 1993; 150: 3671-3680.
33. Cocks B et al. IL-13 induces proliferation and differentiation of human B cells activated by CD40 ligand. Int Immunol 1993; 5: 657-663.
34. Rousset F et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 1992; 89: 1890-1893.
35. Kuhne M et al. Assembly and regulation of the CD40 receptor complex in human B cells. J Exp Med 1997; 186: 337-342.
36. Llorente L et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4(6): 421-427.
37. Tanaka Y. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988; 141(9): 3043-3049.
38. Tsokos G. Lymphocutes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol 1996; 8(5): 395-402.
39. Ma J et al. Autoimmune lpr/lpr mice deficient in CD40 ligand. J Immunol 1996; 157: 417-426.
40. Peng S et al. T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 1997: 158: 2464-2470.
41. Early G, Zhao W, Burns C. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black×New Zealand White Mice. J Immunol 1996; 157: 3159-3164.
42. Mohan C, Shi Y, Laman J et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995; 154: 1470-1480.
43. Desai-Mehta A, Lu L, Ramsey-Goldman R et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97(9): 2063-2073.
44. Koshy M, Berger D, Crow M. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996; 98(3): 826-837.